151 related articles for article (PubMed ID: 38502074)
21. MRI proton density fat fraction for estimation of tumor grade in steatotic hepatocellular carcinoma.
Kupczyk PA; Kurt D; Endler C; Luetkens JA; Kukuk GM; Fronhoffs F; Fischer HP; Attenberger UI; Pieper CC
Eur Radiol; 2023 Dec; 33(12):8974-8985. PubMed ID: 37368108
[TBL] [Abstract][Full Text] [Related]
22. Effect of Intra-Articular Sprifermin vs Placebo on Femorotibial Joint Cartilage Thickness in Patients With Osteoarthritis: The FORWARD Randomized Clinical Trial.
Hochberg MC; Guermazi A; Guehring H; Aydemir A; Wax S; Fleuranceau-Morel P; Reinstrup Bihlet A; Byrjalsen I; Ragnar Andersen J; Eckstein F
JAMA; 2019 Oct; 322(14):1360-1370. PubMed ID: 31593273
[TBL] [Abstract][Full Text] [Related]
23. Reliability of ultrasound hepatorenal index and magnetic resonance imaging proton density fat fraction techniques in the diagnosis of hepatic steatosis, with magnetic resonance spectroscopy as the reference standard.
Tran BV; Ujita K; Taketomi-Takahashi A; Hirasawa H; Suto T; Tsushima Y
PLoS One; 2021; 16(8):e0255768. PubMed ID: 34383812
[TBL] [Abstract][Full Text] [Related]
24. Severe hepatic steatosis promotes increased liver stiffness in the early stages of metabolic dysfunction-associated steatotic liver disease.
Kumada T; Toyoda H; Ogawa S; Gotoh T; Suzuki Y; Sugimoto K; Yoshida Y; Kuroda H; Kamada Y; Sumida Y; Ito T; Akita T; Tanaka J
Liver Int; 2024 Apr; ():. PubMed ID: 38558221
[TBL] [Abstract][Full Text] [Related]
25. Placebo-controlled randomised trial with liraglutide on magnetic resonance endpoints in individuals with type 2 diabetes: a pre-specified secondary study on ectopic fat accumulation.
Bizino MB; Jazet IM; de Heer P; van Eyk HJ; Dekkers IA; Rensen PCN; Paiman EHM; Lamb HJ; Smit JW
Diabetologia; 2020 Jan; 63(1):65-74. PubMed ID: 31690988
[TBL] [Abstract][Full Text] [Related]
26. Aspirin compared with acetaminophen in the treatment of fever and other symptoms of upper respiratory tract infection in adults: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group, single-dose, 6-hour dose-ranging study.
Bachert C; Chuchalin AG; Eisebitt R; Netayzhenko VZ; Voelker M
Clin Ther; 2005 Jul; 27(7):993-1003. PubMed ID: 16154478
[TBL] [Abstract][Full Text] [Related]
27. Effect of Clopidogrel and Aspirin vs Aspirin Alone on Migraine Headaches After Transcatheter Atrial Septal Defect Closure: The CANOA Randomized Clinical Trial.
Rodés-Cabau J; Horlick E; Ibrahim R; Cheema AN; Labinaz M; Nadeem N; Osten M; Côté M; Marsal JR; Rivest D; Marrero A; Houde C
JAMA; 2015 Nov; 314(20):2147-54. PubMed ID: 26551304
[TBL] [Abstract][Full Text] [Related]
28. Effect of a Low Free Sugar Diet vs Usual Diet on Nonalcoholic Fatty Liver Disease in Adolescent Boys: A Randomized Clinical Trial.
Schwimmer JB; Ugalde-Nicalo P; Welsh JA; Angeles JE; Cordero M; Harlow KE; Alazraki A; Durelle J; Knight-Scott J; Newton KP; Cleeton R; Knott C; Konomi J; Middleton MS; Travers C; Sirlin CB; Hernandez A; Sekkarie A; McCracken C; Vos MB
JAMA; 2019 Jan; 321(3):256-265. PubMed ID: 30667502
[TBL] [Abstract][Full Text] [Related]
29. Agreement Between Magnetic Resonance Imaging Proton Density Fat Fraction Measurements and Pathologist-Assigned Steatosis Grades of Liver Biopsies From Adults With Nonalcoholic Steatohepatitis.
Middleton MS; Heba ER; Hooker CA; Bashir MR; Fowler KJ; Sandrasegaran K; Brunt EM; Kleiner DE; Doo E; Van Natta ML; Lavine JE; Neuschwander-Tetri BA; Sanyal A; Loomba R; Sirlin CB;
Gastroenterology; 2017 Sep; 153(3):753-761. PubMed ID: 28624576
[TBL] [Abstract][Full Text] [Related]
30. Effects of Pitavastatin on Insulin Sensitivity and Liver Fat: A Randomized Clinical Trial.
Braun LR; Feldpausch MN; Czerwonka N; Weiss J; Branch K; Lee H; Martinez-Salazar EL; Torriani M; Sponseller CA; Grinspoon SK; Stanley TL
J Clin Endocrinol Metab; 2018 Nov; 103(11):4176-4186. PubMed ID: 30239757
[TBL] [Abstract][Full Text] [Related]
31. Atorvastatin for Anthracycline-Associated Cardiac Dysfunction: The STOP-CA Randomized Clinical Trial.
Neilan TG; Quinaglia T; Onoue T; Mahmood SS; Drobni ZD; Gilman HK; Smith A; Heemelaar JC; Brahmbhatt P; Ho JS; Sama S; Svoboda J; Neuberg DS; Abramson JS; Hochberg EP; Barnes JA; Armand P; Jacobsen ED; Jacobson CA; Kim AI; Soumerai JD; Han Y; Friedman RS; Lacasce AS; Ky B; Landsburg D; Nasta S; Kwong RY; Jerosch-Herold M; Redd RA; Hua L; Januzzi JL; Asnani A; Mousavi N; Scherrer-Crosbie M
JAMA; 2023 Aug; 330(6):528-536. PubMed ID: 37552303
[TBL] [Abstract][Full Text] [Related]
32. Validation of water-fat MRI and proton MRS in assessment of hepatic fat and the heterogeneous distribution of hepatic fat and iron in subjects with non-alcoholic fatty liver disease.
Hui SCN; So HK; Chan DFY; Wong SKH; Yeung DKW; Ng EKW; Chu WCW
Eur J Radiol; 2018 Oct; 107():7-13. PubMed ID: 30292275
[TBL] [Abstract][Full Text] [Related]
33. Effect of Praliciguat on Peak Rate of Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction: The CAPACITY HFpEF Randomized Clinical Trial.
Udelson JE; Lewis GD; Shah SJ; Zile MR; Redfield MM; Burnett J; Parker J; Seferovic JP; Wilson P; Mittleman RS; Profy AT; Konstam MA
JAMA; 2020 Oct; 324(15):1522-1531. PubMed ID: 33079154
[TBL] [Abstract][Full Text] [Related]
34. Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study.
Eriksson JW; Lundkvist P; Jansson PA; Johansson L; Kvarnström M; Moris L; Miliotis T; Forsberg GB; Risérus U; Lind L; Oscarsson J
Diabetologia; 2018 Sep; 61(9):1923-1934. PubMed ID: 29971527
[TBL] [Abstract][Full Text] [Related]
35. Multicenter Validation of Association Between Decline in MRI-PDFF and Histologic Response in NASH.
Loomba R; Neuschwander-Tetri BA; Sanyal A; Chalasani N; Diehl AM; Terrault N; Kowdley K; Dasarathy S; Kleiner D; Behling C; Lavine J; Van Natta M; Middleton M; Tonascia J; Sirlin C;
Hepatology; 2020 Oct; 72(4):1219-1229. PubMed ID: 31965579
[TBL] [Abstract][Full Text] [Related]
36. Safety and Efficacy of Liraglutide, 3.0 mg, Once Daily vs Placebo in Patients With Poor Weight Loss Following Metabolic Surgery: The BARI-OPTIMISE Randomized Clinical Trial.
Mok J; Adeleke MO; Brown A; Magee CG; Firman C; Makahamadze C; Jassil FC; Marvasti P; Carnemolla A; Devalia K; Fakih N; Elkalaawy M; Pucci A; Jenkinson A; Adamo M; Omar RZ; Batterham RL; Makaronidis J
JAMA Surg; 2023 Oct; 158(10):1003-1011. PubMed ID: 37494014
[TBL] [Abstract][Full Text] [Related]
37. Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial.
Dahl D; Onishi Y; Norwood P; Huh R; Bray R; Patel H; Rodríguez Á
JAMA; 2022 Feb; 327(6):534-545. PubMed ID: 35133415
[TBL] [Abstract][Full Text] [Related]
38. Hepatic and renal improvements with FXR agonist vonafexor in individuals with suspected fibrotic NASH.
Ratziu V; Harrison SA; Loustaud-Ratti V; Bureau C; Lawitz E; Abdelmalek M; Alkhouri N; Francque S; Girma H; Darteil R; Couchoux H; Wolf M; Sanyal A; Vonderscher J; Scalfaro P
J Hepatol; 2023 Mar; 78(3):479-492. PubMed ID: 36334688
[TBL] [Abstract][Full Text] [Related]
39. Effect of Aspirin vs Placebo on the Prevention of Depression in Older People: A Randomized Clinical Trial.
Berk M; Woods RL; Nelson MR; Shah RC; Reid CM; Storey E; Fitzgerald S; Lockery JE; Wolfe R; Mohebbi M; Dodd S; Murray AM; Stocks N; Fitzgerald PB; Mazza C; Agustini B; McNeil JJ
JAMA Psychiatry; 2020 Oct; 77(10):1012-1020. PubMed ID: 32492080
[TBL] [Abstract][Full Text] [Related]
40. Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer: The Alliance A011502 Randomized Trial.
Chen WY; Ballman KV; Partridge AH; Hahn OM; Briccetti FM; Irvin WJ; Symington B; Visvanathan K; Pohlmann PR; Openshaw TH; Weiss A; Winer EP; Carey LA; Holmes MD
JAMA; 2024 May; 331(20):1714-1721. PubMed ID: 38683596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
